The Dean lab of the Center for Vector-Borne Infectious Diseases has a major focus on the development of a probiotic vaccine platform utilizing the probiotic organism Lactobacillus acidophilus. Specific applications include vaccines against human rotavirus, feline coronavirus (FECV) and SARS-CoV-2. We study the host mucosal immune response and immune mechanisms of multiple adjuvant strategies. The relationship between the host microbiome and mucosal immunity and the impact of oral vaccination on the intestinal microbiome are also active areas of research. Study of the immunpathogenesis of viral infections is an overarching emphasis.
People
news and updates view all
An international consortium of researchers, led by Dr. Gregg Dean, are collaborating on a program to diagnose, treat and prevent a new form of feline infectious peritonitis in Cyprus.
Sophie Kiehl, an Honors Program student in the Dean & Vilander lab, was selected as a 2024 Astronaut Scholar. The scholarship is awarded to exceptional STEM majors with documented contributions to their fields, who wish to pursue research or further their field.
Paris Kiehl, an Honors Program student in the Dean and Vilander lab, earns the prestigious Goldwater Scholarship Award for demonstrating research excellence and leadership.
contact information
Lab: Center for Vector-Borne Infectious Diseases room 130
Office: Center for Vector-Borne Infectious Diseases room 166
(970) 492-4368
[email protected]